Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1998 2
1999 1
2001 1
2002 1
2003 1
2004 5
2006 1
2007 2
2008 4
2011 1
2012 1
2015 3
2016 5
2017 4
2018 2
2019 1
2020 4
2021 5
2022 6
2023 2
2024 4

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

49 results

Results by year

Filters applied: . Clear all
Page 1
Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA): end-of-study results from a double-blind, randomised, placebo-controlled, phase 3 study.
Swain SM, Miles D, Kim SB, Im YH, Im SA, Semiglazov V, Ciruelos E, Schneeweiss A, Loi S, Monturus E, Clark E, Knott A, Restuccia E, Benyunes MC, Cortés J; CLEOPATRA study group. Swain SM, et al. Lancet Oncol. 2020 Apr;21(4):519-530. doi: 10.1016/S1470-2045(19)30863-0. Epub 2020 Mar 12. Lancet Oncol. 2020. PMID: 32171426 Clinical Trial.
Pertuzumab, trastuzumab, and docetaxel in HER2-positive metastatic breast cancer.
Swain SM, Baselga J, Kim SB, Ro J, Semiglazov V, Campone M, Ciruelos E, Ferrero JM, Schneeweiss A, Heeson S, Clark E, Ross G, Benyunes MC, Cortés J; CLEOPATRA Study Group. Swain SM, et al. N Engl J Med. 2015 Feb 19;372(8):724-34. doi: 10.1056/NEJMoa1413513. N Engl J Med. 2015. PMID: 25693012 Free PMC article. Clinical Trial.
Pertuzumab plus trastuzumab plus docetaxel for metastatic breast cancer.
Baselga J, Cortés J, Kim SB, Im SA, Hegg R, Im YH, Roman L, Pedrini JL, Pienkowski T, Knott A, Clark E, Benyunes MC, Ross G, Swain SM; CLEOPATRA Study Group. Baselga J, et al. N Engl J Med. 2012 Jan 12;366(2):109-19. doi: 10.1056/NEJMoa1113216. Epub 2011 Dec 7. N Engl J Med. 2012. PMID: 22149875 Free PMC article. Clinical Trial.
COVID-19 recovery: implications for cancer care clinicians.
Delany C, Milch V, Keefe D, Wong ZW. Delany C, et al. Among authors: wong zw. Support Care Cancer. 2022 Feb;30(2):1003-1006. doi: 10.1007/s00520-021-06600-3. Epub 2021 Oct 9. Support Care Cancer. 2022. PMID: 34626251 Free PMC article. Review.
Current attempts to implement microRNA-based diagnostics and therapy in cardiovascular and metabolic disease: a promising future.
Thanikachalam PV, Ramamurthy S, Wong ZW, Koo BJ, Wong JY, Abdullah MF, Chin YH, Chia CH, Tan JY, Neo WT, Tan BS, Khan WF, Kesharwani P. Thanikachalam PV, et al. Among authors: wong zw. Drug Discov Today. 2018 Mar;23(3):460-480. doi: 10.1016/j.drudis.2017.10.020. Epub 2017 Oct 28. Drug Discov Today. 2018. PMID: 29107764 Review.
Telehealth in cancer care: during and beyond the COVID-19 pandemic.
Burbury K, Wong ZW, Yip D, Thomas H, Brooks P, Gilham L, Piper A, Solo I, Underhill C. Burbury K, et al. Among authors: wong zw. Intern Med J. 2021 Jan;51(1):125-133. doi: 10.1111/imj.15039. Intern Med J. 2021. PMID: 33572014 Free PMC article.
49 results